Fructosamine oxidase: antagonists and inhibitors
AssigneeProtemix Corporation Limited
InventorJohn Richard Baker
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of treating an individual with diabetes mellitus by administering to said individual an effective amount of copper chelators, hydrazine compounds, and/or substrate analogues. The invention also relates to methods of treating an individual with diabetes mellitus by lessening fructosamine odixase activity in said individual. Provided within is disclosure pertaining to treatment, pharmaceutical compositions, dosage ranges, and uses of fructosamine oxidase enzyme inhibitors to lessen fructosamine oxidase activity.
Claims17
A method of treating a human patient with diabetes mellitus, comprising administering an effective amount of copper chelator to the patient.
A method of treating a human patient with diabetes mellitus, comprising administering triene to the patient in an amount effective to ameliorate macrovascular and microvascular damage in the patient.
Dependencies are inferred from the claim text.